*Reprofiling of Octogenarian Antiviral Agent: A New Avenue Venture to Discover Viral Infection DOI: http://dx.doi.org/10.5772/intechopen.102825*

nonendemic geographical areas such as the USA and Europe. EBOV causes lethal sign and symptoms such as acute hemorrhage, fever, and 90% high fatality rate, it needs high-level biocontainment (BSL-4) which hamper the development of drugs and vaccines to act against EBOV hence no specific therapeutic agents are available yet. In this context, DR prompted the EBOV infection in the last outbreak which shows promising results to lethal the EBOV infection.

Drugs:

